Dr. Andrew Huff

And that was- Sephardic Ashkenazi, basically.

Yes, and that was the finding.

And I think the point that he was trying to make or maybe didn't articulate well is that the agent can be tailored to have that effect.

And that's absolutely true.

And that's through old gain of function technology.

And with synthetic, full synthetics, what I'm saying is you can make this so specific is that if I get your DNA, like off of, you know, say that you threw a cup, I can tailor an agent just to you.

And this is how it's changing.

And if you're using AI behind that, I could then, and I say that a DNA sample from two of your, a couple of your relatives, so I knew what your family tree partially looked like.

Machine learning is very good at actually random forest and tree decision-making.

You do a lot of complex AI behind this to figure out and make predictions that AI could about what your family tree looked like and have the disease travel through your family line.

Now, nobody has ever asked me that question.

I just generated that answer based on what I know, but I think that that is a very real possibility use or application of this type of technology.

It also could be used on the flip side of it.

You could use it to target specific and rare cancers.

And it could be used to eliminate those cancers cleanly and self-deactivate and decompose in a way that didn't harm your body.

So this technology is going to go, could go two different ways, but it's coming because the medical applications and healthcare applications of it.

um, are there and they're going to be, they will be extremely profitable.

Imagine that you said like, I, you know, you have cancer.

I don't have to give you a drug.

I have to inject you with this synthetic, which will seek out the cancer, the tumor in your body and, uh, contain it, kill it with no other harmful effects to your body in theory.